Improvement Needed in Managing UTI in Patients With Neurogenic Bladder
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 2, 2024 -- Expansion of caregiver involvement, enhancement of patient-provider communication, and targeting providers and care settings that lack familiarity with neurogenic bladder (NB) could improve urinary tract infection (UTI) management in this population, according to a study published online Nov. 1 in PLOS ONE.
Margaret A. Fitzpatrick, M.D., from Rocky Mountain Regional VA Medical Center in Aurora, Colorado, and colleagues recruited adults with NB due to spinal cord injury/disorder (SCI/D) or multiple sclerosis (MS) to participate in 11 virtual focus groups. A total of 23 veterans (78 percent with SCI/D; 18.5 percent with MS) were included between May 2021 and May 2022.
The researchers found that three major themes reflected participants' perspectives, experiences, and beliefs about UTI: influence of caregivers; influence of health care environment and provider characteristics; and barriers and facilitators to care. Caregivers promoted care-seeking behavior, enabled care in the home, and improved participant self-efficacy for understanding educational material. Poor perceptions of providers who were not knowledgeable about NB or communicated ineffectively were reported. Self-efficacy to follow provider recommendations was improved by good relationships with providers who knew the participants well.
"Interventions to enhance patient-centeredness of UTI care for these individuals could focus on expanding in-home care by trusted, knowledgeable providers and improving patient-provider communication," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
Ulcerative Hunner Lesions Can Help Characterize Bladder Pain, Infection
TUESDAY, July 2, 2024 -- Distinct phenotypic and urine biological characteristics are seen for patients with interstitial cystitis/bladder pain syndrome (IC/BPS) with a history of...
Biomarkers + Patient-Reported Outcomes Up Prediction of Interstitial Cystitis
TUESDAY, May 7, 2024 -- The integration of biomarkers and patient-reported outcomes (PROs) improves prediction of interstitial cystitis (IC)/bladder pain syndrome, according to a...
FDA Approves New Antibiotic, Pivya, for Uncomplicated Urinary Tract Infections
TUESDAY, April 30, 2024 -- The U.S. Food and Drug Administration has approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.